Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?

Demosthenes G Katritsis1, Mark E Josephson

  • 1Athens Euroclinic, 9 Athanassiadou Street, Athens 11521, Greece. dkatritsis@euroclinic.gr

Insights

Implantable cardioverter defibrillators (ICDs) improve survival in some patients with ventricular arrhythmias, but benefits may be transient with modern therapy. ICDs offer survival benefits primarily in high-risk ischemic cardiomyopathy patients, not solely based on ejection fraction.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Efficacy

Background:

  • Implantable cardioverter defibrillators (ICDs) are used to prevent sudden cardiac death.
  • Evidence regarding the survival benefit and cost-effectiveness of ICDs requires critical analysis.
  • Modern medical therapies, including beta-blockers, may influence ICD efficacy.

Purpose of the Study:

  • To critically analyze the existing evidence on the survival benefits of ICDs.
  • To evaluate the role of ICDs in different patient populations and clinical settings.
  • To assess the cost-effectiveness and appropriate use of ICDs based on current evidence.

Main Methods:

  • Critical analysis of existing scientific evidence and clinical trial data.
  • Review of studies examining ICDs in patients with sustained ventricular arrhythmias and cardiac arrest.
  • Evaluation of ICD efficacy in high-risk patients with ischemic cardiomyopathy and specific ejection fraction thresholds.

Main Results:

  • ICDs confer a survival benefit in patients with documented sustained ventricular arrhythmias or cardiac arrest, though this may be transient with optimal medical therapy.
  • In patients without sustained ventricular arrhythmias, ICDs provide significant survival benefit only in high-risk ischemic cardiomyopathy patients with LVEF ≤ 35% from remote myocardial infarction.
  • Left ventricular ejection fraction alone is insufficient for predicting sudden cardiac death risk; benefits in the elderly and women are not established, and cost-effectiveness is limited to specific high-risk groups.

Conclusions:

  • ICD survival benefits are established in specific high-risk groups but may be overestimated in broader populations.
  • Current guidelines may lead to overuse of ICDs, necessitating a more refined approach to patient selection.
  • Further research is needed to clarify ICD benefits in specific demographics like women and the elderly, and to optimize cost-effectiveness.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...